Rs-43285 (Syntex) A Preliminary Study of A Unique Anti-Anginal Agent
Clin Sci (Lond) (1987) 73 (s17): 38P.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
- U Thadani
- M Ezekowitz
- L Fenney
- Y K Chiang
Circulation (1994) 90 (2): 726.